Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)

Summary

This study is a randomized and controlled phase Ⅳ clinical trial of the COVID-19 vaccine (Vero cell), Inactivated manufactured by Sinovac Research \& Development Co., Ltd. The purpose of this study is to evaluate the immunogenicity and safety of COVID-19 vaccine (Vero cell), Inactivated co-administration with EV71 vaccine

Timeline

Start

2021-11-05

Primary completion

2022-07-14

Completion

2022-07-14

Publications

• Shu Y, Sun Z, Gao F, Huang Z, Meng X, Chen S, Shu Q, Wang L, Zhang H, Ying Z, Zhang J. Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac(R)) co-administered with an inactivated enterovirus type 71 vaccine (Inlive(R)): A phase 4, randomized, controlled trial. Hum Vaccin Immunother. 2024 Dec 31;20(1):2402644. doi: 10.1080/21645515.2024.2402644. Epub 2024 Sep 23.

Drugs

Indications